429 related articles for article (PubMed ID: 23110507)
1. Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines.
Lin CH; Shen YA; Hung PH; Yu YB; Chen YJ
BMC Complement Altern Med; 2012 Oct; 12():201. PubMed ID: 23110507
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.
Li YJ; Wu SL; Lu SM; Chen F; Guo Y; Gan SM; Shi YL; Liu S; Li SL
Tumour Biol; 2015 Apr; 36(4):2747-61. PubMed ID: 25487615
[TBL] [Abstract][Full Text] [Related]
3. EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation.
Lin CH; Chao LK; Hung PH; Chen YJ
Int J Clin Exp Pathol; 2014; 7(5):2372-81. PubMed ID: 24966947
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells.
Nishimura N; Hartomo TB; Pham TV; Lee MJ; Yamamoto T; Morikawa S; Hasegawa D; Takeda H; Kawasaki K; Kosaka Y; Yamamoto N; Kubokawa I; Mori T; Yanai T; Hayakawa A; Takeshima Y; Iijima K; Matsuo M; Nishio H
Environ Health Prev Med; 2012 May; 17(3):246-51. PubMed ID: 21909813
[TBL] [Abstract][Full Text] [Related]
5. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.
Wubetu GY; Shimada M; Morine Y; Ikemoto T; Ishikawa D; Iwahashi S; Yamada S; Saito Y; Arakawa Y; Imura S
J Gastroenterol Hepatol; 2016 Jan; 31(1):256-64. PubMed ID: 26241688
[TBL] [Abstract][Full Text] [Related]
7. EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.
Fang CY; Wu CC; Hsu HY; Chuang HY; Huang SY; Tsai CH; Chang Y; Tsao GS; Chen CL; Chen JY
Int J Mol Sci; 2015 Jan; 16(2):2530-58. PubMed ID: 25625511
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.
Tang SN; Fu J; Nall D; Rodova M; Shankar S; Srivastava RK
Int J Cancer; 2012 Jul; 131(1):30-40. PubMed ID: 21796625
[TBL] [Abstract][Full Text] [Related]
9. Green tea extract and its major constituent epigallocatechin-3-gallate inhibit growth and halitosis-related properties of Solobacterium moorei.
Morin MP; Bedran TB; Fournier-Larente J; Haas B; Azelmat J; Grenier D
BMC Complement Altern Med; 2015 Mar; 15():48. PubMed ID: 25880992
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
Chan KC; Chan LS; Ip JC; Lo C; Yip TT; Ngan RK; Wong RN; Lo KW; Ng WT; Lee AW; Tsao GS; Kahn M; Lung ML; Mak NK
Sci Rep; 2015 Apr; 5():9979. PubMed ID: 25897700
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
Lee SH; Nam HJ; Kang HJ; Kwon HW; Lim YC
Eur J Cancer; 2013 Oct; 49(15):3210-8. PubMed ID: 23876835
[TBL] [Abstract][Full Text] [Related]
12. Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer.
Negri A; Naponelli V; Rizzi F; Bettuzzi S
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30563268
[TBL] [Abstract][Full Text] [Related]
13. Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotype.
Su Z; Li G; Liu C; Ren S; Tian Y; Liu Y; Qiu Y
Oncol Rep; 2016 Jul; 36(1):72-8. PubMed ID: 27108809
[TBL] [Abstract][Full Text] [Related]
14. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis.
Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT-II bladder tumour cell line.
Chen JJ; Ye ZQ; Koo MW
BJU Int; 2004 May; 93(7):1082-6. PubMed ID: 15142168
[TBL] [Abstract][Full Text] [Related]
16. Green tea polyphenols for prostate cancer chemoprevention: a translational perspective.
Johnson JJ; Bailey HH; Mukhtar H
Phytomedicine; 2010 Jan; 17(1):3-13. PubMed ID: 19959000
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways.
Li T; Zhao N; Lu J; Zhu Q; Liu X; Hao F; Jiao X
Bioengineered; 2019 Dec; 10(1):282-291. PubMed ID: 31311401
[TBL] [Abstract][Full Text] [Related]
18. Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition.
Singh T; Katiyar SK
PLoS One; 2011; 6(10):e25224. PubMed ID: 22022384
[TBL] [Abstract][Full Text] [Related]
19. A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression.
Ahn WS; Huh SW; Bae SM; Lee IP; Lee JM; Namkoong SE; Kim CK; Sin JI
DNA Cell Biol; 2003 Mar; 22(3):217-24. PubMed ID: 12804120
[TBL] [Abstract][Full Text] [Related]
20. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
